TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions, has named Glenn Mattes as chief executive officer. Mr. Mattes brings over thirty years of business and industry leadership experience that spans a wide range of businesses and therapeutic categories. Robert Mills, TFF Pharmaceuticals’ chairman of the Board, said, “With Glenn at the helm as o...